Stay updated on LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Difference
    2%
    Check dated 2025-04-23T08:35:40.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page has removed detailed information about a Phase 1 clinical trial for LAVA-051, including key inclusion and exclusion criteria for participants, while adding a new revision number.
    Difference
    22%
    Check dated 2025-04-16T02:05:58.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has been changed from March 25, 2025, to January 27, 2025.
    Difference
    2%
    Check dated 2025-04-08T23:40:05.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page has removed references to Acute Graft Versus Host Disease and added information about Multiple Myeloma.
    Difference
    0.3%
    Check dated 2025-04-01T18:34:21.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Difference
    1%
    Check dated 2025-03-25T13:11:12.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2025-03-18T04:59:11.000Z thumbnail image

Stay in the know with updates to LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page.